The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males

Schizophrenia Research

Volumn 154, Issue 1-3, 2014, Pages 42-47

  Koiliari, Erasmia ^a   Roussos, Panos ^b,c,d   Pasparakis, Emmanouil ^a   Lencz, Todd ^e,f   Malhotra, Anil ^e,f   Siever, Larry J ^b,d   Giakoumaki, Stella G ^a   Bitsios, Panos ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b Department of Psychiatry ^*  (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e ZUCKER HILLSIDE HOSPITAL   (United States)

^f FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Cognition; CSMD1 gene; Endophenotypes; Executive function; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CSMD1 GENE; DECISION MAKING; EXECUTIVE FUNCTION; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GREECE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; INTELLIGENCE QUOTIENT; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGY; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROBLEM SOLVING; SCHIZOPHRENIA; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY; ADOLESCENT; ALLELE; COGNITION; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; INTELLIGENCE TEST; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

CSMD1 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; ALLELES; COGNITION; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXECUTIVE FUNCTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUES; GREECE; HUMANS; INTELLIGENCE TESTS; MALE; MEMBRANE PROTEINS; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84897891825     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.02.017     Document Type: Article

References (52)

1. Bechara A., Damásio A.R., Damásio H., Anderson S.W. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994, 50(1-3):7-15.
2. Bechara A., Damasio H., Tranel D., Anderson S.W. Dissociation of working memory from decision making within the human prefrontal cortex. J. Neurosci. 1998, 18(1):428-437.
3. Birkett P., Sigmundsson T., Sharma T., Toulopoulou T., Griffiths T.D., Reveley A., Murray R. Executive function and genetic predisposition to schizophrenia-the Maudsley family study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147(3):285-293.
4. Bitsios P., Prettyman R., Szabadi E. The inhibition of the pupillary light reflex by the threat of an electric shock: a potential laboratory model of human anxiety. J. Psychopharmacol. 1996, 10(4):279-287.
5. Bitsios P., Szabardi E., Bradshaw C.M. Sensitivity of the fear-inhibited light reflex to diazepam. Psychopharmacology 1998, 135(1):93-98. (Jan).
6. Bitsios P., Szabadi E., Bradshaw C.M. The effects of clonidine on the fear-inhibited light reflex. J. Psychopharmacol. 1998, 12(2):137-145. (Mar).
7. Braver T.S., Cohen J.D., Nystrom L., Jonides J., Smith E.E., Noll D.C. A parametric study of prefrontal cortex involvement in human working memory. NeuroImage 1997, 5(1):49-62.
8. Collette F., Van der Linden M., Delfiore G., Degueldre C., Luxen A., Salmon E. The functional anatomy of inhibition processes investigated with the Hayling task. NeuroImage 2001, 14(2):258-267.
9. Distler M.G., Opal M.D., Dulawa S.C., Palmer A.A. Assessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant mice. PLoS One 2012, 7(12):e51235.
10. Donohoe G., Walters J., Hargreaves A., Rose E.J., Morris D.W., Fahey C., Bellini S., Cummins E., Giegling I., Hartmann A.M., Möller H.J., Muglia P., Owen M.J., Gill M., O'Donovan M.C., Tropea D., Rujescu D., Corvin A. Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. Genes Brain Behav. 2013, 12(2):203-209.
11. Dudbridge F., Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet. Epidemiol. 2008, 32(3):227-234.
12. Ernst M., Bolla K., Mouratidis M., Contoreggi C., Matochik J.A., Kurkian V., Cadet J.L., Kimes A.S., London E.D. Decision-making in a risk-taking task: A PET study. Neuropsychopharmacology 2002, 26(5):682-691.
13. Fukui H., Murai T., Fukuyama H., Hayashi T., Hanakawa T. Functional activity related to risk anticipation during performance of the Iowa Gambling Task. NeuroImage 2005, 24(1):253-259.
14. Giakoumaki S.G., Roussos P., Zouraraki C., Spanoudakis E., Mavrikaki M., Tsapakis E.M., Bitsios P. Sub-optimal parenting is associated with schizotypic and anxiety personality traits in adulthood. Eur. Psychiatry 2013, 28(4):254-260. (May).
15. Glancy M., Barnicoat A., Vijeratnam R., De Souza S., Gilmore J., Huang S., Maloney V.K., Thomas N.S., Bunyan D.J., Jackson A., Barber J.C. Transmitted duplication of 8p23.1-8p23.2 associated with speech delay, autism and learning difficulties. Eur. J. Hum. Genet. 2009, 17(1):37-43.
16. Golden C.J. Stroop Color and Word Test: A Manual for Clinical and Experimental Uses 1978, 1-32. Skoelting, Chicago, Illinois.
17. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160(4):636-645.
18. GTEx Consortium The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 2013, 45(6):580-585.
19. Håvik B., Le Hellard S., Rietschel M., Lybæk H., Djurovic S., Mattheisen M., Mühleisen T.W., Degenhardt F., Priebe L., Maier W., Breuer R., Schulze T.G., Agartz I., Melle I., Hansen T., Bramham C.R., Nöthen M.M., Stevens B., Werge T., Andreassen O.A., Cichon S., Steen V.M. The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol. Psychiatry 2011, 70(1):35-42.
20. Horn N.R., Dolan M., Elliott R., Deakin J.F., Woodruff P.W. Response inhibition and impulsivity: an fMRI study. Neuropsychologia 2003, 41(14):1959-1966.
21. Jutras-Aswad D., Jacobs M.M., Yiannoulos G., Roussos P., Bitsios P., Nomura Y., Liu X., Hurd Y.L. Cannabis-dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: case-control study. PLoS One 2012, 7(6):e39243. (June 22).
22. Keefe R.S., Harvey P.D. Cognitive impairment in schizophrenia. Handb. Exp. Pharmacol. 2012, 213:11-37.
23. Keshavan M.S., Kulkarni S., Bhojraj T., Francis A., Diwadkar V., Montrose D.M., Seidman L.J., Sweeney J. Premorbid cognitive deficits in young relatives of schizophrenia patients. Front. Hum. Neurosci. 2010, 3:62.
24. Kraus D.M., Elliott G.S., Chute H., Horan T., Pfenninger K.H., Sanford S.D., Foster S., Scully S., Welcher A.A., Holers V.M. CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J. Immunol. 2006, 176(7):4419-4430.
25. Lewandowski K.E., Cohen B.M., Keshavan M.S., Ongur D. Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses. Schizophr. Res. 2011, 133(1-3):212-217.
26. McIntosh A.M., Gow A., Luciano M., Davies G., Liewald D.C., Harris S.E., Corley J., Hall J., Starr J.M., Porteous D.J., Tenesa A., Visscher P.M., Deary I.J. Polygenic risk for schizophrenia is associated with cognitive change between childhood and old age. Biol. Psychiatry 2013, 73(10):938-943. (May 15).
27. Meyer-Lindenberg A. From maps to mechanisms through neuroimaging of schizophrenia. Nature 2010, 468(7321):194-202.
28. Newman S.D., Carpenter P.A., Varma S., Just M.A. Frontal and parietal participation in problem solving in the Tower of London: fMRI and computational modelling of planning and high-level perception. Neuropsychologia 2003, 41(2):1668-1682.
29. Owen A.M., Downes J.J., Sahakian B.J., Polkey C.E., Robbins T.W. Planning and spatial working memory following frontal lobe lesions in Man. Neuropsychologia 1990, 28(10):1021-1034.
30. Owen A.M., Morris R.G., Sahakian B.J., Polkey C.E., Robbins T.W. Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Brain 1996, 119(Pt 5):1597-1615.
31. Park S.B., Coull J.T., McShane R.H., Young A.H., Sahakian B.J., Robbins T.W., Cowen P.J. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 1994, 33(3-4):575-588.
32. Patterson N., Price A.L., Reich D. Population structure and eigenanalysis. PLoS Genet. 2006, 2(12):e190. (Dec).
33. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Kane F., Kalidindi S., McDonald C., Howes O., Kravariti E., Demjaha A., Toulopoulou T., Diforti M., Murray R.M., Collier D.A., McGuire P.K. Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol. Psychiatry 2009, 65(6):473-480.
34. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006, 38(8):904-909. (Aug).
35. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., St.Clair D., Corvin A., Gurling H., Werge T., Rujescu D., Blackwood D.H., Pato C.N., Malhotra A.K., Purcell S., Dudbridge F., Neale B.M., Rossin L., Visscher P.M., Posthuma D., Ruderfer D.M., Fanous A., Stefansson H., Steinberg S., Mowry B.J., Golimbet V., De Hert M., Jönsson E.G., Bitter I., Pietiläinen O.P., Collier D.A., Tosato S., Agartz I., Albus M., Alexander M., Amdur R.L., Amin F., Bass N., Bergen S.E., Black D.W., Børglum A.D., Brown M.A., Bruggeman R., Buccola N.G., Byerley W.F., Cahn W., Cantor R.M., Carr V.J., Catts S.V., Choudhury K., Cloninger C.R., Cormican P., Craddock N., Danoy P.A., Datta S., de Hann L., Demontis D., Dikeos D., Djurovic S., Donnelly P., Donohoe G., Duong L., Dwyer S., Fink-Jensen A., Freedman R., Freimer N.B., Friedl M., Georgieva L., Giegling I., Gill M., Glenthøj B., Godard S., Hamshere M., Hansen M., Hansen T., Hartmann A.M., Henskens F.A., Hougaard D.M., Hultman C.M., Ingason A., Jablensky A.V., Jakobsen K.D., Jay M., Jürgens G., Kahn R.S., Keller M.C., Kenis G., Kenny E., Kim Y., Kirov G.K., Konnerth H., Konte B., Krabbendam L., Krausucki R., Lasseter V.K., Laurent C., Lawrence J., Lencz T., Lerer F.B., Liang K.Y., Lichtenstein P., Lieberman J.A., Linszen D.H., Lönnqvist J., Loughland C.M., Maclean A.W., Maher B.S., Maier W., Mallet J., Malloy P., Mattheisen M., Mattinsgsdal M., McGhee K.A., McGrath J.J., McIntosh A., McLean D.E., McQuillin A., Melle I., Michie P.T., Milanova V., Morris D.W., Mors O., Mortensen P.B., Moskvina V., Muglia P., Myin-Germeys I., Nertney D.A., Nestadt G., Nielsen J., Nikolov I., Nordentroft M., Norton N., Nöthen M.M., O'Dushlaine C.T., Olincy A., Olsen L., O'Neill F.A., Ørntoft T., Owen M.J., Pantelis C., Papadimitriou G., Pato M.T., Peltonen L., Petursson H., Pickard B., Pimm J., Pulver A.E., Puri V., Quested D., Quinn E.M., Rasmussen H.B., Réthelyi J.M., Ribble R., Rietschel M., Riley B.P., Ruggeri M., Schall U., Schulze T.G., Schwab S.G., Scott R.J., Shi J., Sigurdsson E., Silverman J.M., Spencer C.C., Stefansson K., Strange A., Strengman E., Stroup T.S., Suvisaari J., Tereniuis L., Thirumalai S., Thygesen J.H., Timm S., Toncheva D., van den Oord E., van Os J., van Winkel R., Veldink J., Walsh D., Wang A.G., Wiersma D., Wildenauer D.B., Williams H.J., Williams N.M., Wormley B., Zammit S., Sullivan P.F., O'Donovan M.C., Daly M.J., Gejman P.V. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43(10):969-976.
36. Rose E.J., Morris D.W., Hargreaves A., Fahey C., Greene C., Gill M., Corvin A., Donohoe G. Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2013, 162B(6):530-537. (Mar 1).
37. Roussos P., Giakoumaki S.G., Adamaki E., Bitsios P. The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males. Biol. Psychiatry 2011, 69(5):479-486. (Mar 1).
38. Roussos P., Giakoumaki S.G., Georgakopoulos A., Robakis N.K., Bitsios P. The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males. Bipolar Disord. 2011, 13(3):250-259. (May).
39. Roussos P., Giakoumaki S.G., Adamaki E., Georgakopoulos A., Robakis N.K., Bitsios P. The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males. Neuropsychopharmacology 2011, 36(8):1677-1688. (Jul).
40. Roussos P., Katsel P., Davis K.L., Bitsios P., Giakoumaki S.G., Jogia J., Rozsnyai K., Collier D., Frangou S., Siever L.J., Haroutunian V. Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. Arch. Gen. Psychiatry 2012, 69(1):7-15. (Jan).
41. Roussos P., Katsel P., Davis K.L., Siever L.J., Haroutunian V. A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch. Gen. Psychiatry 2012, 69(12):1205-1213. (Dec).
42. Roussos P., Katsel P., Davis K.L., Giakoumaki S.G., Lencz T., Malhotra A.K., Siever L.J., Bitsios P., Haroutunian V. Convergent findings for abnormalities of the NF-kappaB signaling pathway in schizophrenia. Neuropsychopharmacology 2013, 38(3):533-539. (Feb).
43. Roussos P., Bitsios P., Giakoumaki S.G., McClure M.M., Hazlett E.A., New A.S., Siever L.J. CACNA1C as a risk factor for schizotypal personality disorder and schizotypy in healthy individuals. Psychiatry Res. 2013, 206(1):122-123. (Mar 30).
44. Rowe J.B., Owen A.M., Johnsrude I.S., Passingham R.E. Imaging the mental components of a planning task. Neuropsychologia 2001, 39(3):315-327.
45. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33.
46. Shimizu A., Asakawa S., Sasaki T., Yamazaki S., Yamagata H., Kudoh J., Minoshima S., Kondo I., Shimizu N. A novel giant gene CSMD3 encoding a protein with CUB and sushi multiple domains: a candidate gene for benign adult familial myoclonic epilepsy on human chromosome 8q23.3-q24.1. Biochem. Biophys. Res. Commun. 2003, 309(1):143-154.
47. Smoller J.W., Kendler K., Craddock N., Ripke S., Kendler K., Lee P.H., Neale B.M., Purcell S., Anney R., Buitelaar J., Fanous A., Faraone S.V., Hoogendijk W., Lesch K.P., Levinson D.F., Perlis R.H., Purcell S., Rietschel M., Riley B., Sonuga-Barke E., Schachar R., Schulze T.G., Thapar A., Craddock N., Kendler K.S., Smoller J.W., Fanous A., Neale B., Neale M., Nurnberger J.I., Perlis R., Purcell S., Rietschel M., Santangelo S., Schulze T.G., Thapar A., Sullivan P.F., Bender P., Cichon S., Craddock N., Daly M.J., Faraone S.V., Kelsoe J., Lehner T., Levinson D., O'Donovan M., Gejman P., Sebat J., Sklar P., Smoller J.W., Daly M.J., Faraone S.V., Daly M., Devlin B., Kelsoe J., Sklar P., Sullivan P., O'Donovan M., Perlis R.H., Neale M.C., Schulze T.G., Anney R., Buitelaar J.K., Faraone S.V., Hoogendijk W.J., Levinson D.F., Lesch K.P., Riley B., Schachar R., Sonuga-Barke E., Absher D., Agartz I., Akil H., Amin F., Andreassen O.A., Anjorin A., Arking D., Asherson P., Azevedo M.H., Backlund L., Badner J.A., Banaschewski T., Barchas J.D., Barnes M.R., Bass N., Bauer M., Bellivier F., Bergen S., Berrettini W., Bettecken T., Biederman J., Binder E.B., Black D.W., Blackwood D.H., Bloss C.S., Boehnke M., Boomsma D.I., Breen G., Breuer R., et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381(9875):1371-1379.
48. Snitz B.E., Macdonald A.W., Carter C.S. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr. Bull. 2006, 32(1):179-194.
49. Terwisscha van Scheltinga A.F., Bakker S.C., van Haren N.E., Derks E.M., Buizer-Voskamp J.E., Boos H.B., Cahn W., Hulshoff Pol H.E., Ripke S., Ophoff R.A., Kahn R.S. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biol. Psychiatry 2013, 73(6):525-531.
50. Toulopoulou T., Goldberg T.E., Mesa I.R., Picchioni M., Rijsdijk F., Stahl D., Cherny S.S., Sham P., Faraone S.V., Tsuang M., Weinberger D.R., Seidman L.J., Murray R.M. Impaired intellect and memory: a missing link between genetic risk and schizophrenia?. Arch. Gen. Psychiatry 2010, 67(9):905-913.
51. Wechsler D. Wechsler Memory Scale, third ed. manual 1997, The Psychological Corporation, San Antonio. third ed. manual.
52. Wirgenes K.V., Djurovic S., Sundet K., Agartz I., Mattingsdal M., Athanasiu L., Melle I., Andreassen O.A. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls. Schizophr. Res. 2010, 122(1-3):31-37.